Emmaus Life Sciences to Present Phase 3 Sickle Cell Disease Clinical Trial Data Mar 31, 2015 10:00am EDT
Emmaus Life Sciences Phase 3 Sickle Cell Disease Trial Data Included In 2015 Highlights Of ASH Program Feb 02, 2015 9:00am EST
Emmaus Life Sciences To Present Phase 3 Sickle Cell Disease Trial Data At 56th American Society Of Hematology Annual Meeting Nov 24, 2014 8:43am EST
Emmaus Life Sciences Announces Positive Top-Line Results Of Its Phase 3 Clinical Trial For Sickle Cell Disease Mar 19, 2014 8:00am EDT
Emmaus Life Sciences Cancels Stock Held By AFH Holding & Advisory And Amir Heshmatpour Jul 01, 2013 8:00am EDT
Emmaus Life Sciences Wins Sweeping Summary Judgment Victory In Suit Against AFH Holding & Advisory and Amir Heshmatpour May 16, 2013 8:00am EDT
Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory Jan 25, 2013 3:40pm EST